Loading ...

Peggy Fitzgibbon

NIAID

https://ned.nih.gov/search/ViewDetails.aspx?NIHID=0013205433

Assessment Group

peggy.fitzgibbon@nih.gov

Work:

240-627-3505

Mobile:

301-808-8962

Address:

NIAID

Committees:

,

Studies:

ITN007AI

-

Treatment With hOKT3gamma1(Ala-Ala) in T1DM

ITN011AI

-

PsA Treatment With hOKT3γ1 (Ala-Ala)

ITN017AI

-

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus

ITN027AI

-

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN037AI

-

ITN038AI

-

ITN041AI

-

A Research Trial of Aralast in New Onset Diabetes

ITN045AI

-

Inducing Remission in Type 1 Diabetes With Alefacept

ITN064AI

-

Imaging of Type 1 Diabetes Progression

ITN065AI

-

TCZ in Pediatric New-onset T1D

ITN066AI

-

Type 1 Diabetes Extension Study

Bio:

Admin Links

Shortcuts

ITN Documents

Links